31
Participants
Start Date
October 31, 2006
Primary Completion Date
November 30, 2010
Study Completion Date
November 30, 2010
Fludarabine
30 mg/m\^2 by vein for 4 Days (Day -10 through Day -7).
Melphalan
140 mg/m\^2 by vein for 1 Day (Day -7).
Umbilical Cord Blood
1 UCB Unit by vein on Day -5.
Rituximab
375 mg/m\^2 by vein once weekly (Days -7, -1, +7, +14) for 4 Weeks (if appropriate).
Peripheral Blood Stem Cell Infusion
Infusion of blood stem cells on Day 0.
UT MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER